Systematic evaluation of immune regulation and modulation-Reference-Cited by-同舟云学术

Systematic evaluation of immune regulation and modulation

Published:2017-03-21 Issue:1 Volume:5 Page:
ISSN:2051-1426
Container-title:Journal for ImmunoTherapy of Cancer
language:en
Short-container-title:j. immunotherapy cancer

Author:

Stroncek David F.,Butterfield Lisa H.,Cannarile Michael A.,Dhodapkar Madhav V.,Greten Tim F.,Grivel Jean Charles,Kaufman David R.,Kong Heidi H.,Korangy Firouzeh,Lee Peter P.,Marincola Francesco,Rutella Sergio,Siebert Janet C.,Trinchieri Giorgio,Seliger Barbara

Publisher

BMJ

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1186/s40425-017-0223-8.pdf

Reference222 articles.

1. Butterfield LH. Cancer vaccines. BMJ. 2015;350:h988.

2. Yuan J, Adamow M, Ginsberg BA, Rasalan TS, Ritter E, Gallardo HF, et al. Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab. Proc Natl Acad Sci U S A. 2011;108:16723–8.

3. Ascierto PA, Kalos M, Schaer DA, Callahan MK, Wolchok JD. Biomarkers for immunostimulatory monoclonal antibodies in combination strategies for melanoma and other tumor types. Clin Cancer Res. 2013;19:1009–20.

4. Ku GY, Yuan J, Page DB, Schroeder SE, Panageas KS, Carvajal RD, et al. Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting: lymphocyte count after 2 doses correlates with survival. Cancer. 2010;116:1767–75.

5. Sarnaik AA, Yu B, Yu D, Morelli D, Hall M, Bogle D, et al. Extended dose ipilimumab with a peptide vaccine: immune correlates associated with clinical benefit in patients with resected high-risk stage IIIc/IV melanoma. Clin Cancer Res. 2011;17:896–906.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring immune status in peripheral blood and tumor tissue in association with survival in patients with multi-organ metastatic colorectal cancer;OncoImmunology;2024-06-10

2. Study of PD-1 Customization and Autoimmune T Cells for Advanced Colorectal Cancer with High MSI Expression;Contrast Media & Molecular Imaging;2022-07-31

3. Development of preclinical and clinical models for immune-related adverse events following checkpoint immunotherapy: a perspective from SITC and AACR;Journal for ImmunoTherapy of Cancer;2021-09

4. XGBoost Classifier Based on Computed Tomography Radiomics for Prediction of Tumor-Infiltrating CD8+ T-Cells in Patients With Pancreatic Ductal Adenocarcinoma;Frontiers in Oncology;2021-05-19

5. SITC cancer immunotherapy resource document: a compass in the land of biomarker discovery;Journal for ImmunoTherapy of Cancer;2020-12